Plc Glaxosmithkline's Net Worth

Plc Glaxosmithkline's net worth is estimated to be at least $29,987,594,372,074.92 as of 11/08/2024. CoreStreet's estimation of Plc Glaxosmithkline's net worth is based on their sale of stock and current holding of stock.

Plc Glaxosmithkline is Major Shareholder at GlaxoSmithKline PLC ADR. They have executed at least 28 trades of stock as per SEC Form 4 filings. Their most recent trade was for 32,005,260 units of GSK stock on 05/20/2021. Their biggest sale was on 05/20/2021 when they sold 32,005,260 units of GlaxoSmithKline PLC ADR stock for $392,064,435.00. They typically trade 3 times per year.

Total value of insider buys:
  • $29,986,939,456,430.00
Total value of insider sells:
  • $654,915,644.92
Most recent insider trade:
  • May 20, 2021

Plc Glaxosmithkline's Insider Trading History

GlaxoSmithKline PLC ADRTitleAmountPriceTypeTotal Value
May 20, 2021
Major Shareholder32,005,260$12.25Sell$392,064,435.00
July 21, 2020
Director361,111$18.00Buy$6,499,998.00
Oct. 18, 2019
Major Shareholder357,142$28.00Buy$9,999,976.00
Sept. 10, 2019
Director177,777$45.00Buy$7,999,965.00
July 1, 2019
Director333,333$15.00Buy$4,999,995.00
May 28, 2019
Director385,714$14.00Buy$5,399,996.00
April 22, 2019
Director325,000$18.00Buy$5,850,000.00
July 30, 2018
Insider148,818$11.00Buy$1,636,998.00
July 17, 2018
Major Shareholder80,000$12.50Buy$1,000,000.00
July 2, 2018
Major Shareholder269,230$13.00Buy$3,499,990.00
Nov. 6, 2017
Major Shareholder428,571$14.00Buy$5,999,994.00
Oct. 24, 2016
Major Shareholder66,500$14.00Buy$931,000.00
Decibel Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 17, 2021
Director150,000$18.00Buy$2,700,000.00
Nkarta IncTitleAmountPriceTypeTotal Value
July 14, 2020
Director833,333$18.00Buy$14,999,994.00
Bicycle Therapeutics LtdTitleAmountPriceTypeTotal Value
July 14, 2020
Major Shareholder1,597$19.27Sell$30,774.19
Progyny IncTitleAmountPriceTypeTotal Value
May 20, 2020
Major Shareholder4,000,000$25.75Sell$103,000,000.00
ChemoCentryx IncTitleAmountPriceTypeTotal Value
Oct. 16, 2018
Insider7,343,492$11.69Sell$85,845,421.48
Liquidia Technologies IncTitleAmountPriceTypeTotal Value
July 30, 2018
Insider148,818$11.00Buy$1,636,998.00
Spero Therapeutics IncTitleAmountPriceTypeTotal Value
July 17, 2018
Major Shareholder80,000$12.50Buy$1,000,000.00
Nov. 6, 2017
Major Shareholder428,571$14.00Buy$5,999,994.00
HTG Molecular Diagnostics IncTitleAmountPriceTypeTotal Value
March 27, 2017
Insider300,000$10.15Sell$3,045,000.00
Theravance Biopharma IncTitleAmountPriceTypeTotal Value
March 14, 2016
Major Shareholder1,301,015$23,028,000.00Buy$29,959,773,420,000.00
Oct. 7, 2015
Major Shareholder44,574$607,544.00Buy$27,080,666,256.00
Applied GeneticTitleAmountPriceTypeTotal Value
Feb. 23, 2015
Major Shareholder503,150$22.00Sell$11,069,300.00
Amicus Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 27, 2014
Major Shareholder11,315,825$5.29Sell$59,860,714.25
Nov. 20, 2013
major shareholder1,500,000$2.00Buy$3,000,000.00
Concert Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Feb. 19, 2014
Major Shareholder35,000$14.00Buy$490,000.00
Genocea Biosciences IncTitleAmountPriceTypeTotal Value
Feb. 10, 2014
Insider143,773$12.00Buy$1,725,276.00